Randomized phase II clinical trial of the anti-HER2 (GP2) vaccine to prevent recurrence in high-risk breast cancer patients: A planned interim analysis.
Francois Trappey
No relevant relationships to disclose
John S. Berry
No relevant relationships to disclose
Timothy J Vreeland
No relevant relationships to disclose
Diane F. Hale
No relevant relationships to disclose
Alan K. Sears
No relevant relationships to disclose
Sathibalan Ponniah
No relevant relationships to disclose
Sonia A. Perez
No relevant relationships to disclose
Guy T. Clifton
No relevant relationships to disclose
Michael Papamichail
No relevant relationships to disclose
George Earl Peoples
No relevant relationships to disclose
Elizabeth Ann Mittendorf
No relevant relationships to disclose